Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →

Clinical Trials Directory

Browse and search research studies sourced from ClinicalTrials.gov and our partner researchers.

48,257 studies found

Recruiting
Study on Sequential Cryoablation, Relaforp Alpha, and Chemotherapy for Bile Duct Tumors

Conditions: Biliary Tract Cancer (BTC)

Department of Radiation Oncology, Tianjin Medical Unive...

View details
Recruiting
HPB-092 for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia

Conditions: Relapsed and Refractory Acute Myeloid Leukemia (RR-AML)

Institute of Hematology and Blood Diseases Hospital, Ti...

View details
Recruiting
BCMA/CD3 BsAb in the Treatment of High-risk Smoldering Multiple Myeloma

Conditions: High Risk Smoldering Multiple Myeloma

Institute of Hematology and Blood Diseases Hospital Chi...

View details
Recruiting
BCMA/CD3 Bispecific Antibody Treatment for Newly Diagnosed Amyloidosis

Conditions: Systemic Light Chain Amyloidosis

Institute of Hematology and Blood Diseases Hospital Chi...

View details
Not Yet Recruiting
Early Response-guided Sequential Radiotherapy After Chemoimmunotherapy for Locally Advanced Eso...

Conditions: Esophageal Squamous Cell Carcinoma (ESCC)

Department of minimally invasive esophageal surgery, Ti...

View details
Not Yet Recruiting
A Phase II Exploratory Study of SR604 Injection Evaluating the Safety and Efficacy in the Treat...

Conditions: Factor VII Deficiency

Institute of Hematology & Blood Diseases Hospital, Chin...

View details
Recruiting
Phase II Study of Becotatug Vedotin Plus Pucotenlimab for Advanced Refractory Solid Tumors With...

Conditions: Advanced Refractory Solid Tumors, EGFR Gene Overexpression

Tianjin Medical Unversity Second Hospital Tianjin Tianj...

View details
Recruiting
Neoadjuvant EGFR-ADC Combined With Anti-PD-1 Monoclonal Antibody in Resectable Locally Advanced...

Conditions: Hypopharyngeal Squamous Cell Carcinoma

Tianjin Medical University Cancer Institute and Hospita...

View details
Recruiting
A Single-Arm Clinical Trial of Percutaneous Splenic Ablation Combined With Splenic Artery Occlu...

Conditions: Secondary Hypersplenism

Tianjin Medical University Cancer Institute & Hospital...

View details
Recruiting
Efficacy and Safety of Tislelizumab in Combination With Disitamab-vedotin as Neoadjuvant Therap...

Conditions: Neoadjuvant Immunotherapy

The Second Hospital of Tianjin Medical University Tianj...

View details
Active Not Recruiting
Multimodal Prediction of Postoperative Prognosis After Partial Nephrectomy for Endophytic Renal...

Conditions: Renal Cell Carcinoma, Kidney Neoplasms, Endophytic Renal Tumor, Postoperative Re...

Tianjin Medical University Second Hospital Tianjin Tian...

View details
Recruiting
Hypofractionated Radiotherapy After Complete Resection for Stage II/III Thymic Epithelial Tumor...

Conditions: Thymic Epithelial Tumor

Tianjin Medical University Cancer Institute and Hospita...

View details
Recruiting
Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuv...

Conditions: Pancreatic Cancer, Adult

Tianjin Medical University Cancer Institute and Hospita...

View details
Not Yet Recruiting
SYH2095 for Advanced Malignant Tumors: Phase I Study

Conditions: Advanced Malignant Tumors

Tianjin Medical University Cancer Institute and Hospita...

View details
Not Yet Recruiting
META 10-19 in Patients With Relapsed/Refractory Autoimmune Hemolytic Anemia

Conditions: Autoimmune Hemolytic Anemia (AIHA)

Blood Diseases Hospital, Chinese Academy of Medical Sci...

View details
Not Yet Recruiting
Acupuncture for Heel Pain Syndrome

Conditions: Heel Pain Syndrome

The First Teaching Hospital of Tianjin University of Tr...

View details
Not Yet Recruiting
Eltrombopag Plus Telitacicept vs. Eltrombopag Alone for Steroid-refractory/Relapsed ITP

Conditions: Immune Thrombocytopenia

Ethics Committee of Blood disease hospital, Chinese Aca...

View details
Not Yet Recruiting
Sonrotoclax and BCMA Bispecific Antibody in Newly Diagnosed Systemic AL Amyloidosis Based on t(...

Conditions: Multiple Myeloma (MM)

Institute of Hematology and Blood Diseases Hospital Chi...

View details
Recruiting
Study of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW107) as Prophylactic...

Conditions: Severe Hemophilia A

Institute of Hematology & Blood Diseases Hospital Chine...

View details
Recruiting
CM336 Plus Isatuximab for Newly Diagnosed Multiple Myeloma With Renal Impairment

Conditions: Multiple Myeloma (MM), Multiple Myeloma Light Chain Induced Renal Insufficiency

Institute of Hematology and Blood Diseases Hospital Chi...

View details
Active Not Recruiting
A Prospective Clinical Study of CD3-CD20 Bisspecific Antibody Based Therapy Combined With CD19-...

Conditions: B-cell Non-Hodgkin Lymphoma

Institute of Hematology and Blood Diseases Hospital ,Ch...

View details
Active Not Recruiting
A Study of VRD-based Regimen Combined With CART-ASCT-CART2 Treatment in Patients With Primary P...

Conditions: Plasma Cell Leukemia

Institute of Hematology and Blood Diseases Hospital Chi...

View details
Recruiting
CD5 CART for the Treatment of Relapsed and Refractory CD5 Hematological Tumors

Conditions: Relapsed and Refractory CD5 Hematological Tumors

Hematology Hospital of Chinese Academy of Medical Scien...

View details
Recruiting
A Multicenter, Open-label Study on the Efficacy and Safety of Tebiovio® (Adalimumab) in Treatin...

Conditions: Adult Non-infectious Uveitis

Tianjin Medical University Eye Hospital Tianjin Tianjin...

View details